Drugs / Influvacplus 2005/2006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00783380 | Oct 2005 → Jul 2006 | immunodeficiency disease | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influvacplus 2005/2006 | “Influvacplus 2005/2006, Solvay Pharma AG, Bern, Switzerland Assigned to all 4 groups if immunocompromized patients” NCT00783380 ↗ |